Jeffrey Silbiger, MD

img_Jeffrey Silbiger
PROFESSOR | Medicine, Cardiology
Research Topics
Anatomy, Cardiovascular, Imaging
Arrhythmic Mitral Valve Prolapse
This research utilized cardiac magnetic resonance imaging to examine the patho-anatomy of mitral annular disjunction (MAD) in patients with mitral valve prolapse. It demonstrated that MAD is accompanied by anomalous attachment of the posterior annulus to the left ventricle with implications for the pathogenesis of malignant ventricular arrhythmias.
Coronary Artery Disease in High Risk Populations
This research examined the risk factor profile and angiographic findings of high risk CAD populations of South Asian descent (Indians, Bangladeshis, Pakistanis and Guyanese) .
Mitral Annulus Anatomy and Function
This research focused on the role anatomic perturbations of the mitral annulus play in the pathogenesis of mitral valve disease. This work, which entailed gross dissection and histological examination of human and bovine hearts, led to a number of novel insights including the role of the left atrium in annular contraction and the mechanistic role of atriogenic leaflet tethering in atrial functional mitral regurgitation.
Left Ventricular Remodeling
This work employed echocardiographic strain imaging to examine the role of left ventricular false tendons in maintaining normal left ventricular size and shape and in preventing adverse remodeling after myocardial infarction.

BS, City College of New York

Fellowship, Mout Sinai-Beth Israel Hospital

MD, New York Medical College

Residency, Nassau County Medical Center

2024

Cardiology Fellows' Award for Excellence in Teaching

Mount Sinai Clinical Cardiology Fellowship Program

2022

Cariology Fellows' Award for Excellence in Teaching

Mount Sinai Clinical Cardiology Fellowship Program

2021

Cardiology Fellows’ Award for Excellence in Teaching

Mount Sinai Clinical Cardiology Fellowship Program

2017

Cardiology Fellows’ Award for Excellence in Teaching

Mount Sinai Clinical Cardiology Fellowship Program

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Silbiger during 2025 and/or 2026. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • GE Healthcare

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.